Cite
HARVARD Citation
Adams, R. et al. (2021). Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial. Journal of clinical oncology. 39 (33), pp. 3693-3704. [Online].